123 related articles for article (PubMed ID: 10748912)
1. Assessment of the immunological surveillance value of humoral and lymphocyte assays in severe human cystic echinococcosis.
Bonifacino R; Carter SD; Craig PS; Almeida I; Da Rosa D
Trans R Soc Trop Med Hyg; 2000; 94(1):97-102. PubMed ID: 10748912
[TBL] [Abstract][Full Text] [Related]
2. Albendazole treatment and serological follow-up in hydatid disease of bone.
Bonifacino R; Dogliani E; Craig PS
Int Orthop; 1997; 21(2):127-32. PubMed ID: 9195269
[TBL] [Abstract][Full Text] [Related]
3. Long-term evaluation of patients with hydatidosis treated with albendazole and praziquantel.
Haralabidis S; Diakou A; Frydas S; Papadopoulos E; Mylonas A; Patsias A; Roilides E; Giannoulis E
Int J Immunopathol Pharmacol; 2008; 21(2):429-35. PubMed ID: 18547489
[TBL] [Abstract][Full Text] [Related]
4. Post-treatment follow-up study of abdominal cystic echinococcosis in tibetan communities of northwest Sichuan Province, China.
Li T; Ito A; Pengcuo R; Sako Y; Chen X; Qiu D; Xiao N; Craig PS
PLoS Negl Trop Dis; 2011 Oct; 5(10):e1364. PubMed ID: 22039558
[TBL] [Abstract][Full Text] [Related]
5. Using specific synthetic peptide (p176) derived AgB 8/1-kDa accompanied by modified patient's sera: a novel hypothesis to follow-up of Cystic echinococcosis after surgery.
Rouhani S; Parvizi P; Spotin A
Med Hypotheses; 2013 Oct; 81(4):557-60. PubMed ID: 23890801
[TBL] [Abstract][Full Text] [Related]
6. Immune status during albendazole therapy for hydatidosis.
Matossian RM; Awar GN; Radwan H; Craig PS; Meshefedjian GA
Ann Trop Med Parasitol; 1992 Feb; 86(1):67-75. PubMed ID: 1616397
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of human cystic echinococcosis before and after surgery and chemotherapy by demonstration of antibodies in serum.
Tenguria RK; Naik MI
Ann Parasitol; 2014; 60(4):297-303. PubMed ID: 25706429
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of cystic echinococcosis: systematic review and meta-analysis.
Velasco-Tirado V; Alonso-Sardón M; Lopez-Bernus A; Romero-Alegría Á; Burguillo FJ; Muro A; Carpio-Pérez A; Muñoz Bellido JL; Pardo-Lledias J; Cordero M; Belhassen-García M
BMC Infect Dis; 2018 Jul; 18(1):306. PubMed ID: 29976137
[TBL] [Abstract][Full Text] [Related]
9. Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates.
Riganò R; Ioppolo S; Ortona E; Margutti P; Profumo E; Ali MD; Di Vico B; Teggi A; Siracusano A
Clin Exp Immunol; 2002 Sep; 129(3):485-92. PubMed ID: 12197890
[TBL] [Abstract][Full Text] [Related]
10. Role of chemotherapeutic agents in the management of cystic echinococcosis.
Nazligul Y; Kucukazman M; Akbulut S
Int Surg; 2015 Jan; 100(1):112-4. PubMed ID: 25594649
[TBL] [Abstract][Full Text] [Related]
11. Case report: clinical and serological evaluation of echinococcosis of the spine.
El-On J; Ben-Noun L; Galitza Z; Ohana N
Trans R Soc Trop Med Hyg; 2003; 97(5):567-9. PubMed ID: 15307428
[TBL] [Abstract][Full Text] [Related]
12. Monitored medico-surgical approach to the treatment of cystic hydatidosis.
Awar GN; Matossian RM; Radwan H; Meshefedjian GA
Bull World Health Organ; 1991; 69(4):477-82. PubMed ID: 1934242
[TBL] [Abstract][Full Text] [Related]
13. Benzimidazole treatment of cystic echinococcosis.
El-On J
Acta Trop; 2003 Feb; 85(2):243-52. PubMed ID: 12606103
[TBL] [Abstract][Full Text] [Related]
14. Disseminated Cystic Echinococcosis Cured With Lengthy Albendazole and Praziquantel Oral Therapy.
Mantadakis E; Totikidis G; Deftereos S
Pediatr Infect Dis J; 2021 Aug; 40(8):e319. PubMed ID: 34250981
[No Abstract] [Full Text] [Related]
15. Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease.
Riganò R; Profumo E; Ioppolo S; Notargiacomo S; Ortona E; Teggi A; Siracusano A
Clin Exp Immunol; 1995 Nov; 102(2):281-5. PubMed ID: 7586679
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effects of chitosan-praziquantel and chitosan-albendazole nanoparticles on Echinococcus granulosus Metacestodes.
Torabi N; Dobakhti F; Faghihzadeh S; Haniloo A
Parasitol Res; 2018 Jul; 117(7):2015-2023. PubMed ID: 29616349
[TBL] [Abstract][Full Text] [Related]
17. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China.
Wen H; Zou PF; Yang WG; Lu J; Wang YH; Zhang JH; New RR; Craig PS
Trans R Soc Trop Med Hyg; 1994; 88(3):340-3. PubMed ID: 7974683
[TBL] [Abstract][Full Text] [Related]
18. Serological monitoring of progression of alveolar echinococcosis with multiorgan involvement by use of recombinant Em18.
Ishikawa Y; Sako Y; Itoh S; Ohtake T; Kohgo Y; Matsuno T; Ohsaki Y; Miyokawa N; Nakao M; Nakaya K; Ito A
J Clin Microbiol; 2009 Oct; 47(10):3191-6. PubMed ID: 19656973
[TBL] [Abstract][Full Text] [Related]
19. Favourable prognostic value of antibodies anti-HSP20 in patients with cystic echinococcosis: a differential immunoproteomic approach.
Vacirca D; Perdicchio M; Campisi E; Delunardo F; Ortona E; Margutti P; Teggi A; Gottstein B; Siracusano A
Parasite Immunol; 2011 Mar; 33(3):193-8. PubMed ID: 21306401
[TBL] [Abstract][Full Text] [Related]
20. Partial characterization of antigens in circulating immune complexes in cystic hydatid patients treated with albendazole.
Bonifacino R; Craig P; Carter S; Malgor R; Dixon J
Trans R Soc Trop Med Hyg; 1993; 87(1):97-102. PubMed ID: 8465413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
